🇮🇱 War Epicenter | Palantir Bullets #60
NIH, Option Care Health, Thiel and Karp in Israel
Editor: Emanuele Marabella
Hi, I’m Arny. Please hit the ❤️ button if you enjoy today’s article.
Subscribe to @arny_trezzi on X
Last week:
PLTR 0.00%↑ expanded the partnership started in 2020 with the University of Colorado Anschutz Med. Campus. The goal is to establish the Center for Linkage and Acquisition of Data, which is part of the NIH’s All of Us Research Program. After an initial 18-month base period, the award may be renewed annually for up to four additional years.
Palantir was selected by Option Care Health for a multi-year partnership. AIP will be used across the company to improve patient outcomes and increase efficiency. In particular, AIL will support nurse scheduling, patient onboarding, purchasing optimization and supply chain execution. Option Care Health is the nation’s largest independent provider of home and alternate site infusion services with +7,500 employees and operating in all 50 states.
Palantir hosted its first board of director meeting in Israel to reiterate its support against Hamas. In an interview, CEO Karp hinted that the products of the company are in great demand.
“We’re not a monoculture. There are people who disagree with our decisions everywhere, especially our decision to support Israel. They vocally disagree with it and their voices are heard. And we are moving forward with our support of Israel.” - Alex Karp, Palantir CEO, with The Times of Israel
Palantir released the highlights of its Prix event that happened last month:
Speeches from clients included NYSE, BCG, Lowe’s Mount Sinai:
Palantweets
Tweet of the week
Yours,
Arny
Would you like to learn more about PLTR directly with me?
Book a meeting with Arny Trezzi
Book a meeting with Arny Trezzi
Reach me:
arnylaorca@gmail.com
Disclaimer: The views and opinions expressed above are current as of the date of this document and are subject to change without notice. Materials referenced above will be provided for educational purposes only. None of the above will include investment advice, a recommendation or an offer to sell, or a solicitation of an offer to buy, any securities or investment products